Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

piramal critical care, inc. - levothyroxine sodium anhydrous (unii: 054i36cpmn) (levothyroxine - unii:q51bo43mg4) - levothyroxine sodium for injection is indicated for the treatment of myxedema coma. important limitations of use: the relative bioavailability between levothyroxine sodium for injection and oral levothyroxine products has not been established. caution should be used when switching patients from oral levothyroxine products to levothyroxine sodium for injection as accurate dosing conversion has not been studied. none. 8.1 pregnancy pregnancy category a – there are no reported cases of levothyroxine sodium for injection used to treat myxedema coma in patients who were pregnant or lactating. studies in pregnant women treated with oral levothyroxine to maintain a euthyroid state have not shown an increased risk of fetal abnormalities. therefore, pregnant patients who develop myxedema should be treated with levothyroxine sodium for injection as the risk of non-treatment is associated with a high probability of significant morbidity or mortality to the maternal patient and the fetus. 8.2 labor and delivery patie

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

piramal critical care inc - isoflurane (unii: cys9akd70p) (isoflurane - unii:cys9akd70p) - isoflurane may be used for induction and maintenance of general anesthesia. adequate data have not been developed to establish its application in obstetrical anesthesia. isoflurane is contraindicated in patients: • in whom general anesthesia is contraindicated. • with known sensitivity to isoflurane or to other halogenated agents. • with known or suspected genetic susceptibility to malignant hyperthermia (see warnings /malignant hyperthermia, clinical pharmacology / pharmacogenomics). • with a history of confirmed hepatitis due to a halogenated inhalational anesthetic or a history of unexplained moderate to severe hepatic dysfunction (e.g., jaundice associated with fever and/or eosinophilia) after anesthesia with isoflurane or other halogenated inhalational anesthetics.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

piramal critical care inc - isoflurane (unii: cys9akd70p) (isoflurane - unii:cys9akd70p) - isoflurane may be used for induction and maintenance of general anesthesia. adequate data have not been developed to establish its application in obstetrical anesthesia. isoflurane is contraindicated in patients: • in whom general anesthesia is contraindicated. • with known sensitivity to isoflurane or to other halogenated agents. • with known or suspected genetic susceptibility to malignant hyperthermia (see warnings /malignant hyperthermia, clinical pharmacology / pharmacogenomics). • with a history of confirmed hepatitis due to a halogenated inhalational anesthetic or a history of unexplained moderate to severe hepatic dysfunction (e.g., jaundice associated with fever and/or eosinophilia) after anesthesia with isoflurane or other halogenated inhalational anesthetics

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

piramal critical care inc. - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - 1.1 pneumonia cefepime for injection is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae, including cases associated with concurrent bacteremia, pseudomonas aeruginosa, klebsiella pneumoniae, or enterobacter species. 1.2 empiric therapy for febrile neutropenic patients cefepime for injection as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studie s ( 14.1)]. 1.3 uncomplicated and complicated urinary tract infections (including pyelonephritis) cefepime for injection is indicated in the treatment of uncomplicated and co

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

piramal critical care inc - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane, usp is indicated for induction and maintenance of general anesthesia in dogs. sevoflurane is contraindicated in dogs with a known sensitivity to sevoflurane or other halogenated agents.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

piramal critical care inc - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - petrem is indicated for induction and maintenance of general anesthesia in dogs. petrem is contraindicated in dogs with a known sensitivity to sevoflurane or other halogenated agents.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

piramal critical care inc - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - before instituting treatment with ceftriaxone for injection, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. therapy may be instituted prior to obtaining results of susceptibility testing. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection and other antibacterial drugs, ceftriaxone for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection is indicated for the treatment of the following infections when caused by susceptible organisms: lower respiratory tract infections caused by streptococcus p

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

piramal critical care inc - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - before instituting treatment with ceftriaxone for injection appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. therapy may be instituted prior to obtaining results of susceptibility testing. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection and other antibacterial drugs, ceftriaxone for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection is indicated for the treatment of the following infections when caused by susceptible organisms: lower respiratory tract infections caused by streptococcus p

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

piramal critical care inc - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid injection is indicated for the treatment of nosocomial pneumonia caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates) or streptococcus pneumoniae [ see clinical studies ( 14) ] . linezolid injection is indicated for the treatment of community-acquired pneumonia caused by streptococcus pneumoniae , including cases with concurrent bacteremia, or staphylococcus aureus (methicillin-susceptible isolates only) [ see clinical studies ( 14) ] . linezolid injection is indicated for the treatment of complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis, caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus pyogenes , or streptococcus agalactiae . linezolid injection has not been studied in the treatment of decubitus ulcers [see clinical studies ( 14) ]. linezolid injection is indicated for the treatment of uncomplicated sk

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

piramal critical care inc - tazobactam sodium (unii: uxa545abtt) (tazobactam - unii:se10g96m8w), piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx) - 1.1 intra-abdominal infections piperacillin and tazobactam for injection is indicated in adults and pediatric patients (2 months of age and older) for the treatment of appendicitis (complicated by rupture or abscess) and peritonitis caused by beta-lactamase producing isolates of escherichia coli or the following members of the bacteroides fragilis group: b. fragilis, b. ovatus, b. thetaiotaomicron, or b. vulgatus . 1.2 nosocomial pneumonia piperacillin and tazobactam for injection is indicated in adults and pediatric patients (2 months of age and older) for the treatment of nosocomial pneumonia (moderate to severe) caused by beta-lactamase producing isolates of staphylococcus aureus and by piperacillin/tazobactam-susceptible acinetobacter baumannii, haemophilus influenzae, klebsiella pneumoniae , and pseudomonas aeruginosa ( nosocomial pneumonia caused by p. aeruginosa should be treated in combination with an aminoglycoside) [see dosage and administration ( 2)]. 1.3